Sales revenue for China’s time-honored traditional Chinese medicine(TCM)producer Tongrentang,which has a history reaching back 342 years,hit 13 billion yuan($2 billion) in 2010,with profit of 1 billion yuan($153 mill...Sales revenue for China’s time-honored traditional Chinese medicine(TCM)producer Tongrentang,which has a history reaching back 342 years,hit 13 billion yuan($2 billion) in 2010,with profit of 1 billion yuan($153 million).Overseas development was another high-light of its development with export earnings reaching$28 million.By far,Tongrentang has been China’s top exporter of Chinese patent drugs for 11 years.Today,Tongrentang has set up two展开更多
Objective:To understand the overseas development and legislation status of traditional Chinese medicine(TCM),find out the current development problems,so as to better promote the development of TCM in the world.Method...Objective:To understand the overseas development and legislation status of traditional Chinese medicine(TCM),find out the current development problems,so as to better promote the development of TCM in the world.Methods:Through the data of CNKI and Wanfang,we searched for the keywords"international Chinese medicine","Chinese medicine legislation","world Chinese medicine"and"Chinese medicine development".A total of more than 60 literatures were searched and finally summarized.Results:At present,TCM in Western countries belongs to alternative medicine or complementary medicine.The spread and influence of TCM in the world is expanding,and the international cooperation and exchange of TCM has also entered a period of rapid development.Many countries and regions in the world have made specific regulations on the medical and educational undertakings of TCM,and many countries and regions have enacted legislation on TCM.Conclusion:At present,many countries and regions in different continents have legalized TCM.However,due to the differences in concepts,cultural backgrounds,laws and regulations in different regions,there are still obstacles to the legislation and development TCM in overseas countries.The overseas legislation and development of TCM have long road,and efforts are still needed.展开更多
The Bank of China has achieved steadyand considerable development invarious overseas businesses,hasexpanded,and has enhanced its overall strengthand made a tremendous contribution to thedevelopment of the State’s eco...The Bank of China has achieved steadyand considerable development invarious overseas businesses,hasexpanded,and has enhanced its overall strengthand made a tremendous contribution to thedevelopment of the State’s economicconstruction and foreign trade.At present,the Bank of China has 519 overseas agencies,distributed in 19 countries and regions.As ofthe end of June 1995,the total assets value inoverseas branches had surpassed US＄ 150billion.This information was revealed byWang Xuebing,the Chairman of the展开更多
A co-operative contract to set up China’s largest joint-venture power project in Shandong Province, was initiated by.four partners on June 7 at Beijing’s Great Hall of the People. The project’s total investment is ...A co-operative contract to set up China’s largest joint-venture power project in Shandong Province, was initiated by.four partners on June 7 at Beijing’s Great Hall of the People. The project’s total investment is expected to be about $2.3 billion, of which a little over $1 billion will be raised overseas. The partners in the massive power projects are Shandong Electric Power Corp, Shandong International Trust and Investment Corp, Electricite de展开更多
In this paper, we study the location distribution and determinants for Chinese firms’ overseas Research and Development(R&D) activities, based on a dataset of 1,500 Chinese firms that established overseas R&D...In this paper, we study the location distribution and determinants for Chinese firms’ overseas Research and Development(R&D) activities, based on a dataset of 1,500 Chinese firms that established overseas R&D subsidiaries during the years 2010-2014. Integrating Dunning’s eclectic paradigm and Uppsala Model, we construct a two-dimensional model, which consists of the determinants from host countries and from the interactions between the host countries and the home country, China. We use a multiple-regression method to analyze the determinants and rationale of the location choice of Chinese firms’ overseas R&D activities. By identifying the determinants of the location of the Chinese firms, we aim to reveal whether and where the location strategy of Chinese firms’ R&D globalization differs from those of the firms in the U.S., Europe and Japan;and to provide a reference for Chinese firms in their strategy-making on R&D globalization.展开更多
China President Xi Jin-ping met with Dr. Margaret Chan, Director-General of the World Health Organization （WHO）, at the Great Hall of the People in Beijing, capital of China, Aug. 20, 2013. XI Jin-ping said that Chi...China President Xi Jin-ping met with Dr. Margaret Chan, Director-General of the World Health Organization （WHO）, at the Great Hall of the People in Beijing, capital of China, Aug. 20, 2013. XI Jin-ping said that China will continue to improve public health and enhance cooperation with the WHO. The Chinese government always prioritizes its people＇s health and will make unremitting efforts to further implement reform of its public health system, Xi said. He promised that the Chinese government would continue to effectively distribute public health and medical resources in order to achieve full coverage of basic health services to all Chinese people by 2020.展开更多
文摘Sales revenue for China’s time-honored traditional Chinese medicine(TCM)producer Tongrentang,which has a history reaching back 342 years,hit 13 billion yuan($2 billion) in 2010,with profit of 1 billion yuan($153 million).Overseas development was another high-light of its development with export earnings reaching$28 million.By far,Tongrentang has been China’s top exporter of Chinese patent drugs for 11 years.Today,Tongrentang has set up two
文摘Objective:To understand the overseas development and legislation status of traditional Chinese medicine(TCM),find out the current development problems,so as to better promote the development of TCM in the world.Methods:Through the data of CNKI and Wanfang,we searched for the keywords"international Chinese medicine","Chinese medicine legislation","world Chinese medicine"and"Chinese medicine development".A total of more than 60 literatures were searched and finally summarized.Results:At present,TCM in Western countries belongs to alternative medicine or complementary medicine.The spread and influence of TCM in the world is expanding,and the international cooperation and exchange of TCM has also entered a period of rapid development.Many countries and regions in the world have made specific regulations on the medical and educational undertakings of TCM,and many countries and regions have enacted legislation on TCM.Conclusion:At present,many countries and regions in different continents have legalized TCM.However,due to the differences in concepts,cultural backgrounds,laws and regulations in different regions,there are still obstacles to the legislation and development TCM in overseas countries.The overseas legislation and development of TCM have long road,and efforts are still needed.
文摘The Bank of China has achieved steadyand considerable development invarious overseas businesses,hasexpanded,and has enhanced its overall strengthand made a tremendous contribution to thedevelopment of the State’s economicconstruction and foreign trade.At present,the Bank of China has 519 overseas agencies,distributed in 19 countries and regions.As ofthe end of June 1995,the total assets value inoverseas branches had surpassed US＄ 150billion.This information was revealed byWang Xuebing,the Chairman of the
文摘A co-operative contract to set up China’s largest joint-venture power project in Shandong Province, was initiated by.four partners on June 7 at Beijing’s Great Hall of the People. The project’s total investment is expected to be about $2.3 billion, of which a little over $1 billion will be raised overseas. The partners in the massive power projects are Shandong Electric Power Corp, Shandong International Trust and Investment Corp, Electricite de
基金supported by the Department of Science and Technology of Guangdong Province,Soft Science Research Project(2015B070702004)“Monitoring and evaluation of innovation-driven development and regional comparison in Guangdong province”the National Natural Science Foundation of China(NSFC)Project(71672184)“The evolution of innovation ecosystem and formation of competitive advantage-approach of ecosystem rent”
文摘In this paper, we study the location distribution and determinants for Chinese firms’ overseas Research and Development(R&D) activities, based on a dataset of 1,500 Chinese firms that established overseas R&D subsidiaries during the years 2010-2014. Integrating Dunning’s eclectic paradigm and Uppsala Model, we construct a two-dimensional model, which consists of the determinants from host countries and from the interactions between the host countries and the home country, China. We use a multiple-regression method to analyze the determinants and rationale of the location choice of Chinese firms’ overseas R&D activities. By identifying the determinants of the location of the Chinese firms, we aim to reveal whether and where the location strategy of Chinese firms’ R&D globalization differs from those of the firms in the U.S., Europe and Japan;and to provide a reference for Chinese firms in their strategy-making on R&D globalization.
文摘China President Xi Jin-ping met with Dr. Margaret Chan, Director-General of the World Health Organization （WHO）, at the Great Hall of the People in Beijing, capital of China, Aug. 20, 2013. XI Jin-ping said that China will continue to improve public health and enhance cooperation with the WHO. The Chinese government always prioritizes its people＇s health and will make unremitting efforts to further implement reform of its public health system, Xi said. He promised that the Chinese government would continue to effectively distribute public health and medical resources in order to achieve full coverage of basic health services to all Chinese people by 2020.
